
Bexson Biomedical recently signed a deal with the Stevanato Group to develop a subcutaneous delivery system of ketamine.
“SG EZ-be Pod,” a wearable device designed for administering subcutaneous drugs, would facilitate patient administration of medications outside of clinics and hospitals.